BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Triamcinolone

A glucocorticoid given, as the free alcohol or in esterified form, orally, intramuscularly, by local injection, by inhalation, or applied topically in the management of various disorders in which corticosteroids are indicated. (From Martindale, The Extra Pharmacopoeia, 30th ed, p739)

300+ PubMed studies analyzed · 28 RCTs · Evidence Score: 47.3

Research Domains

Triamcinolone has been studied across 14 research domains including ✨ Skin & Hair, 👁️ Vision & Eye, 🔬 Inflammation, 🦴 Bone & Joint, 🫘 Kidney. The primary research focus is ✨ Skin & Hair with 21% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Triamcinolone, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Medroxyprogesterone
11 shared targets
Beclomethasone
12 shared targets
Triamcinolone
11 shared targets
Hydrocortisone
11 shared targets
Prednisone
9 shared targets
Flurandrenolone
8 shared targets
Dydrogesterone
10 shared targets
Methyltestosterone
11 shared targets
Methylprednisolone
8 shared targets
Melengestrol
10 shared targets
Loading evidence profile...

This evidence profile for Triamcinolone is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.